Discrimination of agonist and antagonist forms of CXCL10 in biological samples

Autor: M. Schmolz, Stanislas Pol, L. Stephen, Matthew L. Albert, James Mapes, Armanda Casrouge, Vincent Mallet, C. Pfister, A. Bisiaux

Publikováno v: Clinical and Experimental Immunology
Clinical and Experimental Immunology, Wiley, 2012, 167 (1), pp.137-148. ⟨10.1111/j.1365-2249.2011.04488.x⟩
Clinical and Experimental Immunology, 2012, 167 (1), pp.137-148. ⟨10.1111/j.1365-2249.2011.04488.x⟩
Clinical and Experimental Immunology, Wiley, 2012, 167 (1), pp.137-148. 〈10.1111/j.1365-2249.2011.04488.x〉

Summary The ready access to commercially available multiplex assays and the importance of inflammation in disease pathogenesis has resulted in an abundance of studies aimed at identifying surrogate biomarkers for different clinically important questi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebab0338538bea4fe091429d1a353338
https://hal-pasteur.archives-ouvertes.fr/pasteur-01402047